3SBIO

Read more
Jing Lou's photo - Chairman & CEO of 3SBIO

Chairman & CEO

Jing Lou

CEO Approval Rating

71/100

Founded:

1993

Status:

PublicIndependent CompanyNASDAQSSRX

3SBIO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Celltrion is a top competitor of 3SBIO. Celltrion was founded in 2002, and is headquartered in Incheon, Gyeonggido. Like 3SBIO, Celltrion also competes in the Pharmaceuticals field. Celltrion generates $213.5M more revenue vs. 3SBIO.

Innovent Biologics is seen as one of 3SBIO's top competitors. Innovent Biologics is headquartered in Suzhou, Jiangsu Province, and was founded in 2011. Like 3SBIO, Innovent Biologics also operates in the Pharmaceuticals field. Innovent Biologics generates 77% the revenue of 3SBIO.

Sino Biological has been one of 3SBIO's top competitors. Sino Biological's headquarters is in Beijing, Beijing Municipality, and was founded in 2007. Sino Biological is in the Biotechnology industry. Sino Biological generates 3.94% of 3SBIO's revenue.

3SBIO Quarterly and Annual Revenue

Coming soon for 3SBIO!

Annual Revenue

$761M

3SBIO's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 5.1B.

3SBIO Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Contract Development and Manufacturing Business, Therapure Biopharma Inc.

Sep 2017

Source »
$290M
-
Shanghai CP Guojian Pharmaceutical Co., Ltd.

Dec 2015

Source »
undisclosed
Shanghai CP Guojian Pharmaceutical researches, develops, manufactures and markets antibody drugs.
Zhejiang Wansheng Co., Ltd

Jul 2015

Source »
$85M
Zhejiang Wansheng is engaged in the research, development, manufacture and sale of organophosphorus flame retardant and polymer polyols.

These are all the companies that 3SBIO has acquired. 3SBIO has acquired 3 companies and its latest acquisition was Contract Development and Manufacturing Business, Therapure Biopharma Inc. in Sep 2017.

3SBIO Funding History

Since 3SBIO was founded in 1993, it has participated in 1 round of funding. In total 3SBIO has raised $712.0M. 3SBIO's funding round was on May 2015 for a total of $712.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
May 2015
$712M
-

Since 3SBIO was founded in 1993, it has participated in 1 round of funding. In total 3SBIO has raised $712.0M. 3SBIO's funding round was on May 2015 for a total of $712.0M

3SBIO Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

-
May 18, 2021
Series C
-
Verseau is a Massachusetts-based biotechnology company that discovers and repolarizes macrophages for the treatment of cancer.
$50M
Oct 20, 2019
Equity
-
Refuge Biotech develops a genetic engineering platform that focuses on gene editing of immune cells for cancer immunotherapy.
$10M
May 01, 2018
Series B
-

These are all the companies that 3SBIO has invested in. 3SBIO has invested 3 companies and its latest investment was Contract Development and Manufacturing Business, Therapure Biopharma Inc. in Sep 2017.

3SBIO News

August 26, 2020MarketScreener

ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION FOR AMPHOLIPAD IN MAINLAND CHINA

(marketscreener.com) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Lim... See more »
August 19, 2020MarketScreener

VOLUNTARY ANNOUNCEMENT - 3SBIO INC. OBTAINED APPROVAL FROM NATIONAL MEDICAL PRODUCTS ADMINISTRATION TO LAUNCH NADROPARIN CALCIUM INJECTION

(marketscreener.com) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Lim... See more »
August 17, 2020MarketScreener

Maintains Steady Growth in 1H 2020 More than 10 NDAs to be submitted in the next 3 years

(marketscreener.com) August 17, 2020, Hong Kong--- Chinese leading biopharmaceutical company 3SBio(01... See more »
July 31, 2020MarketScreener

VOLUNTARY ANNOUNCEMENT - SETTLEMENT OF LEGAL PROCEEDINGS

(marketscreener.com) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Lim... See more »
July 17, 2020ChinaBio Today

Sunshine Guojian, a 3SBio Subsidiary, Plans $248 Million Shanghai STAR Board IPO

Sunshine Guojian Pharma (Shanghai), a 3SBio subsidiary that develops antibody drugs, is planning a $2... See more »
June 28, 2020MarketScreener

Sunshine Guojian obtained clinical trial approval by the FDA for the anti-IL-4R monoclonal antibody

(marketscreener.com) 3SBio Inc. , a leading biopharmaceutical company in China, announced today that ... See more »
March 31, 2020BioPortfolio

3SBio Unveils 2019 Annual Results Revenue Rises by 16.0 Normalized Net Profit attributable to owners of the parent Jumps by19.4 R&D Expenses Soar 45.2

HONGKONG March 31 2020 PRNewswire Chinese leading biopharmaceutical company 3SBio 01530.HK today rele... See more »

3SBIO Press Releases

September 18, 2016Business Wire

Chemotherapy Induced Anemia Therapeutics Pipeline Review 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Chemotherapy Induced... See more »
August 25, 2016NewsMaker

Global Therapeutics Landscape of Thrombopoietin Receptor Pipeline Review, H1 2016

Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene cMpl or CD110 or MPL) ... See more »
July 13, 2016Business Wire

Global Anemia in Chronic Kidney Disease Therapeutics (Renal Anemia) Pipeline Report 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Anemia in Chronic Ki... See more »
July 12, 2016PR Newswire

3S Bio, Sihuan, LG Life Sciences

DUBLIN, July 12, 2016 /PRNewswire/ -- Research and Markets has announced the addition of the "rhEPO M... See more »

3SBIO Videos

Social Media

3SBIO Headquarters

No.3 A1, Road 10 Shenyang Economy & Technology Development Zone

Shenyang, Liaoning Province110027

86-24-2538-6000

Driving Directions »

Trending Companies

3SBIO Summary

ABOUT

Overview

3SBio develops, manufactures and markets bio-pharmaceutical products. 3SBIO was founded in 1993. 3SBIO's headquarters is located in Shenyang, Liaoning Province, CN 110027. It has raised 712.0M in 1 round. The latest round was in May 2015. 3SBIO's late...

CEO

3SBIO's Chairman & CEO, Jing Lou, currently has an approval rating of 71%. 3SBIO's primary competitors are Celltrion, Innovent Biologics & Sino Biological.

Website

3sbio.com

Frequently Asked Questions about 3SBIO

  1. When was 3SBIO founded?

    3SBIO was founded in 1993
  2. Who is 3SBIO's CEO?

    3SBIO's CEO is Jing Lou
  3. How much revenue does 3SBIO generate?

    3SBIO generates $761M in revenue
  4. How much funding does 3SBIO have?

    3SBIO has historically raised $712M in funding
  5. Where is 3SBIO's headquarters?

    3SBIO's headquarters is in Shenyang Liaoning Province, CN
  1. How many employees does 3SBIO have?

    3SBIO has 5,404 employees
  2. What sector does 3SBIO operate in?

    3SBIO is in Pharmaceuticals
  3. Who are 3SBIO's competitors?

    3SBIO's top competitors are Celltrion, Innovent Biologics, Sino Biological
  4. Who has 3SBIO invested in?

    3SBIO's has invested in companies such as Genequantum, Verseau, Refuge Biotechnologies, Inc.